Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7929 USD | -3.90% | -37.07% | -29.21% |
05-15 | Top Midday Decliners | MT |
05-15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.21% | 30.23M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- Bolt Biotherapeutics : Stifel Starts Bolt Biotherapeutics at Buy With $40 Price Target